Rapid Micro Biosystems Announces New Chief Executive Officer
Rapid Micro Biosystems, a leading provider of automated, non-destructive, rapid microbial detection, announced today that its Board of Directors has named seasoned industry veteran Robert Spignesi as the company’s next chief executive officer. As the new CEO of Rapid Micro Biosystems, Rob’s priorities will be leading the Company to support the business expansion and widespread adoption of the Growth Direct™ System.
Rob has more than 20 years of leadership experience and joined Rapid Micro Biosystems most recently from Thermo Fisher Scientific, where he was a Vice President and General Manager, Americas. Previously, Rob was the VP of Global Strategy, Marketing and Business Development for Fisher Scientific and held senior roles at McKesson Corporation and its affiliates, including EVP Operations and Development and Vice President of Sales and Business Development within the pharmacy systems and automation group. Earlier in his career, he was a senior consultant within the Life Sciences and Healthcare practice of Deloitte Consulting and an aviation officer with the U.S. Army. Rob holds a B.S. in economics from the United States Military Academy at West Point and an MBA from Columbia University where he was the Dr. Donald Bibeault Scholar.
“Rob is the perfect fit for Rapid Micro Biosystems,” said Richard Kollender, Chairman of the Board of Rapid Micro Biosystems and Partner at Quaker Partners. “His industry experience and proven track record of leading business growth provides the right blend of skills to lead the business forward.”
“I am excited to join Rapid Micro Biosystems at such a pivotal time in the company’s history,” commented Mr. Spignesi. “With the launch of the Growth Direct™ and the positive customer response, I am eager to lead the organization through this exciting phase of growth.”
Tags: Microbial Limit Testing, Sterility Testing, Bioburden
Date Published: October 21, 2014
Source article link: Rapid Micro Biosystems » company contact details
Lonza to Sell and Distribute Rapid Bioburden Testing Technology
Sterisart® Sterility Testing – Minimizes Contamination Risk
Count Single Bacterial Cells in Minutes with the QUANTOM Tx™ Microbial Cell Counter
Cherwell Achieves >20% Increase in Redipor® Sales to Overseas Distributors